Clinical Trial Update: A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 trial compares Pola-RCHP-X against RCHOP-X and Pola-RCHP in previously untreated diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Pola-RCHP
• Pola-RCHP-X
• RCHOP-X
• Rituximab (rituximab)
• Vincristine (vincristine)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING